CGT
IONS icon

Capital Guardian Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Capital Guardian Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-134
Closed -$5K – 735
2016
Q1 		$5K Buy
+134
New +$5.44K ﹤0.01% 682

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Capital Guardian Trust's IONS Position: Q2 2016 in Review

Capital Guardian Trust sold out of Ionis Pharmaceuticals (IONS) in Q2 2016, closing a stake of 134 shares — an estimated $5K sold.

Capital Guardian Trust first reported a position in IONS in Q1 2016 and held it in 1 quarter. The position peaked at $5K in Q1 2016. 282 funds tracked by Wall St. Rank hold IONS as of Q2 2016.

  • Capital Guardian Trust reported no remaining Ionis Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Capital Guardian Trust sold 134 Ionis Pharmaceuticals shares in Q2 2016, an estimated $5K.
  • Capital Guardian Trust first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • Capital Guardian Trust's Ionis Pharmaceuticals position peaked at $5K in Q1 2016.
  • 282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2016.

Based on Capital Guardian Trust's 13F filing for Q2 2016, filed 15 Aug 2016.